Orbminco Limited (ASX:OB1)

Market Cap	3.40M
Revenue (ttm)	71.48K
Net Income (ttm)	-9.29M
Shares Out	3.40B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000,000
Average Volume	3,314,332
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0020
Beta	1.26
RSI	47.21
Earnings Date	Sep 19, 2025

About Achilles Therapeutics

Orbminco Limited, together with its subsidiaries, operates as an exploration company in Australia and Mongolia. The company holds interest in the Bronze Fox project that covers 175 square kilometers located in the Southern Gobi porphyry belt of southern Mongolia; and 100% interest in the Mt Cattlin lithium project located in Ravensthorpe east-southeast of Perth in Western Australia. The company was formerly known as Woomera Mining Limited and changed its name to Orbminco Limited in December 2024. The company was incorporated in 1996 and is base...

• Industry: Other Industrial Metals & Mining
• Sector: Materials
• Founded: 1996
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OB1

Financial Performance

In 2024, Orbminco's revenue was 71,483, an increase of 10553.20% compared to the previous year's 671. Losses were -4.15 million, 10.6% more than in 2023.